{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:45:23Z","timestamp":1781768723379,"version":"3.54.5"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/mat.0b013e31826d6070","type":"journal-article","created":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T10:24:24Z","timestamp":1350383064000},"page":"554-561","source":"Crossref","is-referenced-by-count":31,"title":["Alloimmunosensitization in Left Ventricular Assist Device Recipients and Impact on Posttransplantation Outcome"],"prefix":"10.1097","volume":"58","author":[{"given":"Marian","family":"Urban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Gazdic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Slimackova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Pirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Szarszoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Maly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Netuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.healun.2011.07.007","article-title":"Percutaneous balloon occlusion of a left ventricular assist device outflow cannula to facilitate evaluation of myocardial recovery.","volume":"58","author":"Potapov","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R2-5-20210129","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.healun.2011.08.003","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report-2011.","volume":"30","author":"Stehlik","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.healun.2005.09.003","article-title":"International Society for Heart and Lung Transplantation. Acute antibody-mediated rejection of cardiac transplants.","volume":"25","author":"Reed","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.jtcvs.2006.11.062","article-title":"Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions.","volume":"133","author":"Drakos","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S1053-2498(02)00448-5","article-title":"HLA alloimmunization in patients requiring ventricular assist device support.","volume":"21","author":"McKenna","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"R7-5-20210129","first-page":"876","article-title":"Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support.","volume":"17","author":"Moazami","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0003-4975(97)00807-2","article-title":"Factors influencing HLA sensitization in implantable LVAD recipients.","volume":"64","author":"Massad","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/pcad.2000.7191","article-title":"Immunobiology of left ventricular assist devices.","volume":"43","author":"Itescu","year":"2000","journal-title":"Prog Cardiovasc Dis"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/01.CIR.98.8.786","article-title":"Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation.","volume":"98","author":"Itescu","year":"1998","journal-title":"Circulation"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1053-2498(00)00459-9","article-title":"Allosensitization following left ventricular assist device (LVAD) implantation is dependent on CD40-CD40 ligand interactions.","volume":"20","author":"Schuster","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jtcvs.2007.11.049","article-title":"Association of device surface and biomaterials with immunologic sensitization after mechanical support.","volume":"135","author":"George","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R17-5-20210129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.healun.2008.11.908","article-title":"HLA sensitization in pediatric pre-transplant cardiac patients supported by mechanical assist devices: the utility of Luminex.","volume":"28","author":"Yang","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.humimm.2009.06.015","article-title":"Alloantibodies in heart transplantation.","volume":"70","author":"Ho","year":"2009","journal-title":"Hum Immunol"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1399-3046.2005.00394.x","article-title":"The virtual crossmatch-a screening tool for sensitized pediatric heart transplant recipients.","volume":"10","author":"Zangwill","year":"2006","journal-title":"Pediatr Transplant"},{"key":"R21-5-20210129","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00007890-199402270-00014","article-title":"Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ.","volume":"57","author":"Tyan","year":"1994","journal-title":"Transplantation"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.4049\/jimmunol.143.12.4104","article-title":"Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig.","volume":"143","author":"Rossi","year":"1989","journal-title":"J Immunol"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2249.1993.tb03407.x","article-title":"Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg).","volume":"92","author":"Vassilev","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/0140-6736(93)91784-J","article-title":"Immunologically active proteins in intravenous immunoglobulin.","volume":"342","author":"Lam","year":"1993","journal-title":"Lancet"},{"key":"R25-5-20210129","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.athoracsur.2011.04.064","article-title":"Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab.","volume":"92","author":"Lick","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"R27-5-20210129","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jtcvs.2010.03.037","article-title":"Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.","volume":"140","author":"John","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R28-5-20210129","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.healun.2005.06.028","article-title":"Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes.","volume":"24","author":"Joyce","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R29-5-20210129","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1067\/mtc.2003.30","article-title":"Immunologic sensitization in recipients of left ventricular assist devices.","volume":"125","author":"John","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R33-5-20210129","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S1053-2498(01)00232-7","article-title":"Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival.","volume":"20","author":"Pagani","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"R34-5-20210129","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.healun.2003.12.008","article-title":"Relationship between bridging with ventricular assist device on rejection after heart transplantation.","volume":"24","author":"Pamboukian","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R35-5-20210129","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.healun.2005.06.028","article-title":"Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes.","volume":"24","author":"Joyce","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R36-5-20210129","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/00007890-200505150-00041","article-title":"Early and midterm risk of coronary allograft vasculopathy in patients bridged to orthotopic heart transplantation with ventricular assist devices.","volume":"79","author":"Gonzalez-Stawinski","year":"2005","journal-title":"Transplantation"},{"key":"R37-5-20210129","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.healun.2006.09.008","article-title":"Rituximab as monotherapy for elicited xenoreactive antibody responses.","volume":"25","author":"Gonzalez-Stawinski","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R38-5-20210129","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.healun.2011.12.001","article-title":"The Fourth INTERMACS Annual Report: 4,000 implants and counting.","volume":"31","author":"Kirklin","year":"2012","journal-title":"J Heart Lung Transplant"}],"container-title":["ASAIO Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002480-201211000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T08:45:33Z","timestamp":1714466733000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002480-201211000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mat.0b013e31826d6070","relation":{},"ISSN":["1058-2916"],"issn-type":[{"value":"1058-2916","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}